Correlation Between Gilead Sciences and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Puma Biotechnology, you can compare the effects of market volatilities on Gilead Sciences and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Puma Biotechnology.
Diversification Opportunities for Gilead Sciences and Puma Biotechnology
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Gilead and Puma is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Gilead Sciences and Puma Biotechnology
Given the investment horizon of 90 days Gilead Sciences is expected to generate 1.03 times less return on investment than Puma Biotechnology. But when comparing it to its historical volatility, Gilead Sciences is 3.22 times less risky than Puma Biotechnology. It trades about 0.03 of its potential returns per unit of risk. Puma Biotechnology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 412.00 in Puma Biotechnology on September 13, 2024 and sell it today you would lose (110.00) from holding Puma Biotechnology or give up 26.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Puma Biotechnology
Performance |
| Timeline |
| Gilead Sciences |
| Puma Biotechnology |
Gilead Sciences and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Puma Biotechnology
The main advantage of trading using opposite Gilead Sciences and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Gilead Sciences vs. Puma Biotechnology | Gilead Sciences vs. Iovance Biotherapeutics | Gilead Sciences vs. Sarepta Therapeutics | Gilead Sciences vs. Day One Biopharmaceuticals |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |